Serum lipids and incidence of coronary heart disease: Findings from the systolic hypertension in the elderly program (SHEP)

Circulation

Volumn 94, Issue 10, 1996, Pages 2381-2388

  Frost, Philip H ^a   Davis, Barry R ^b   Burlando, Alfredo J ^c   David Curb, J ^d   Guthrie, Gordon P ^e   Isaacsohn, Jonathan L ^f   Wassertheil Smoller, Sylvia ^g   Wilson, Alan C ^h   Stamler, Jeremiah ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f CHRIST HOSPITAL   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cholesterol; coronary disease; lipids; lipoproteins; risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029806745     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.10.2381     Document Type: Article

References (36)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Predicting coronary heart disease in middle-aged and older persons; the Framingham Study. JAMA. 1977;238:497-499.
2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High-density lipoprotein as a protective factor against coronary heart disease. Am J Med. 1977;62:707-714.
3. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis. 1978;31:201-306.
4. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. Ann Intern Med. 1979;90:85-91.
5. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee D-J, Sherwin R, Shih J, Stamler J, Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 1992;152:1490-1500.
6. Barrett-Connor E, Suarez L, Khaw K, Criqui MH, Wingard DL. Ischemic heart disease risk factors after age 50. J Chron Dis. 1984;37:903-908.
7. Castelli WP, Wilson WF, Levy D, Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol. 1989;63:12H-19H.
8. Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA. 1990;263:393-396.
9. Rubin SM, Sidney S, Black DM, Browner WS, Hulley SB, Cummings SR. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med. 1990;113:916-920.
10. Shipley MJ, Pocock SJ, Marmot MG. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in the Whitehall Study. BMJ. 1991;303:89-92.
11. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82:191-222.
12. Kannel WB, Larson M. Long-term epidemiologic prediction of coronary disease: the Framingham experience. Cardiology. 1993;82: 137-152.
13. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol. 1992;2: 161-176.
14. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, I: reduction in incidence of coronary heart disease, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:351-364.
15. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233-3240.
16. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitainiemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-1245.
17. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990;264:3007-3012.
18. Brown BG, Albers JJ, Fisher LD, Schaeffer SM, Lin J-T, Kapfan C, Zhao X-Q, Bisson BD, Fitzpatrick VK, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
19. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD, Sawin HS, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmer TC, and the POSCH Group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med. 1990;323:946-955.
20. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990;336:129-133.
21. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W, for the Coronary Drug Project Research Group. Fifteen year mortality in coronary drug project patients: Long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245-1255.
22. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
23. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
24. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
25. Hall WD, Davis BR, Frost P, Hoffmeier M, O'Brien JE, Pace S, Page L, Scheider KA, Stamler J. Systolic Hypertension in the Elderly Program (SHEP): baseline characteristics of the randomized SHEP participants, Part 7: baseline laboratory characteristics. Hypertension. 1991;17(suppl II):102-122.
26. Havel RJ, Rapaport E, Management of primary hyperlipidemia. N Engl J Med. 1995;332:1491-1498.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-552.
28. Cox DR. Regression models and life-tables. J Royal Stat Soc. 1972;34:187-220.
29. Black HR, Curb JD, Pressel S, Probstfield JL, Stamler J (eds). Systolic Hypertension in the Elderly Program (SHEP). Hypertension. 1991;17(suppl II).
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
31. Krumholz HM, Seeman TE, Merrill SS, de Leon M, Vaccarino V, Silverman DI, Tsukahara R, Ostfeld AM, Berkman LF. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272:1335-1340.
32. Corti M-C, Gurainik JM, Salive ME, Harris T, Field TS, Wallace RB, Berkman LF, Seeman TE. Glynn RJ, Hennekens CH, Havlik RJ. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995;274:539-544.
33. Law MR, Walk NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-373.
34. Law MR, Waid NJ, Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ. 1994;308:363-366.
35. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: Results from the CASS Registry. N Engl J Med. 1988;319:1365-1369.
36. Pedersen TR, Kjekshus J, Pyorala K, Wilhelmsen L, Haghfelt T, Thorgeirson G, for the 4S Group. Effect of simvastatin on survival and coronary morbidity in coronary heart disease patients 65 or older. Circulation. 1995;92(suppl I)-672. Abstract.